{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:16:03Z","timestamp":1789265763099,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Charitable contributions to Silent Spring Institute\u2019s Safer Chemicals Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Factors that increase estrogen or progesterone (P4) action are well-established as increasing breast cancer risk, and many first-line treatments to prevent breast cancer recurrence work by blocking estrogen synthesis or action. In previous work, using data from an in vitro steroidogenesis assay developed for the U.S. Environmental Protection Agency (EPA) ToxCast program, we identified 182 chemicals that increased estradiol (E2up) and 185 that increased progesterone (P4up) in human H295R adrenocortical carcinoma cells, an OECD validated assay for steroidogenesis. Chemicals known to induce mammary effects in vivo were very likely to increase E2 or P4 synthesis, further supporting the importance of these pathways for breast cancer. To identify additional chemical exposures that may increase breast cancer risk through E2 or P4 steroidogenesis, we developed a cheminformatics approach to identify structural features associated with these activities and to predict other E2 or P4 steroidogens from their chemical structures. First, we used molecular descriptors and physicochemical properties to cluster the 2,012 chemicals screened in the steroidogenesis assay using a self-organizing map (SOM). Structural features such as triazine, phenol, or more broadly benzene ramified with halide, amine or alcohol, are enriched for E2 or P4up chemicals. Among E2up chemicals, phenol and benzenone are found as significant substructures, along with nitrogen-containing biphenyls. For P4up chemicals, phenol and complex aromatic systems ramified with oxygen-based groups such as flavone or phenolphthalein are significant substructures. Chemicals that are active for both E2up and P4up are enriched with substructures such as dihydroxy phosphanedithione or are small chemicals that contain one benzene ramified with chlorine, alcohol, methyl or primary amine. These results are confirmed with a chemotype ToxPrint analysis. Then, we used machine learning and artificial intelligence algorithms to develop and validate predictive classification QSAR models for E2up and P4up chemicals. These models gave reasonable external prediction performances (balanced accuracy\u2009~\u20090.8 and Matthews Coefficient Correlation\u2009~\u20090.5) on an external validation. The QSAR models were enriched by adding a confidence score that considers the chemical applicability domain and a ToxPrint assessment of the chemical. This profiling and these models may be useful to direct future testing and risk assessments for chemicals related to breast cancer and other hormonally-mediated outcomes.<\/jats:p>","DOI":"10.1038\/s41598-022-24889-w","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T15:08:02Z","timestamp":1669820882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cheminformatics analysis of chemicals that increase estrogen and progesterone synthesis for a breast cancer hazard assessment"],"prefix":"10.1038","volume":"12","author":[{"given":"Alexandre","family":"Borrel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruthann A.","family":"Rudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"key":"24889_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2015-1010","volume":"36","author":"AC Gore","year":"2015","unstructured":"Gore, A. C. et al. EDC-2: The endocrine society\u2019s second scientific statement on endocrine-disrupting chemicals. Endocr. Rev. 36, 1\u2013150 (2015).","journal-title":"Endocr. Rev."},{"key":"24889_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA. Cancer J. Clin."},{"key":"24889_CR3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/jnci\/djh025","volume":"96","author":"GA Colditz","year":"2004","unstructured":"Colditz, G. A., Rosner, B. A., Chen, W. Y., Holmes, M. D. & Hankinson, S. E. Risk factors for breast cancer according to estrogen and progesterone receptor status. J. Natl. Cancer Inst. 96, 218\u2013228 (2004).","journal-title":"J. Natl. Cancer Inst."},{"key":"24889_CR4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1289\/ehp.1307455","volume":"122","author":"RA Rudel","year":"2014","unstructured":"Rudel, R. A., Ackerman, J. M., Attfield, K. R. & Brody, J. G. New exposure biomarkers as tools for breast cancer epidemiology, biomonitoring, and prevention: A systematic approach based on animal evidence. Environ. Health Perspect. 122, 881\u2013895 (2014).","journal-title":"Environ. Health Perspect."},{"key":"24889_CR5","doi-asserted-by":"crossref","first-page":"077003","DOI":"10.1289\/EHP8608","volume":"129","author":"B Cardona","year":"2021","unstructured":"Cardona, B. & Rudel, R. A. Application of an in vitro assay to identify chemicals that increase Estradiol and progesterone synthesis and are potential breast cancer risk factors. Environ. Health Perspect. 129, 077003 (2021).","journal-title":"Environ. Health Perspect."},{"key":"24889_CR6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.steroids.2014.12.011","volume":"99","author":"FZ Stanczyk","year":"2015","unstructured":"Stanczyk, F. Z., Mathews, B. W. & Sherman, M. E. Relationships of sex steroid hormone levels in benign and cancerous breast tissue and blood: A critical appraisal of current science. Steroids 99, 91\u2013102 (2015).","journal-title":"Steroids"},{"key":"24889_CR7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.2020.9482","volume":"324","author":"RT Chlebowski","year":"2020","unstructured":"Chlebowski, R. T. et al. Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women\u2019s health initiative randomized clinical trials. JAMA J. Am. Med. Assoc. 324, 369\u2013380 (2020).","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"24889_CR8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14096-2","volume":"362","author":"E Banks","year":"2003","unstructured":"Banks, E. et al. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362, 419\u2013427 (2003).","journal-title":"Lancet"},{"key":"24889_CR9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/0192623309354108","volume":"38","author":"SV Fernandez","year":"2010","unstructured":"Fernandez, S. V. & Russo, J. Estrogen and Xenoestrogens in breast cancer. Toxicol. Pathol. 38, 110\u2013122 (2010).","journal-title":"Toxicol. Pathol."},{"key":"24889_CR10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.envres.2017.08.045","volume":"160","author":"KM Rodgers","year":"2018","unstructured":"Rodgers, K. M., Udesky, J. O., Rudel, R. A. & Brody, J. G. Environmental chemicals and breast cancer: An updated review of epidemiological literature informed by biological mechanisms. Environ. Res. 160, 152\u2013182 (2018).","journal-title":"Environ. Res."},{"key":"24889_CR11","doi-asserted-by":"publisher","unstructured":"OECD. Test No. 456: H295R Steroidogenesis Assay. (OECD, 2011). https:\/\/doi.org\/10.1787\/9789264122642-en.","DOI":"10.1787\/9789264122642-en"},{"key":"24889_CR12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.yrtph.2012.04.004","volume":"63","author":"SN Kolle","year":"2012","unstructured":"Kolle, S. N. et al. A testing strategy for the identification of mammalian, systemic endocrine disruptors with particular focus on steroids. Regul. Toxicol. Pharmacol. 63, 259\u2013278 (2012).","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"24889_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14800\/ccm.1216","volume":"1","author":"\u00c9 Caron-beaudoin","year":"2016","unstructured":"Caron-beaudoin, \u00c9. & Sanderson, J. T. Effects of neonicotinoids on promoter-specific expression and activity of aromatase: Implications for the development of hormone-dependent breast cancer. Cancer Cell Microenviron. 1, 1\u20135. https:\/\/doi.org\/10.14800\/ccm.1216 (2016).","journal-title":"Cancer Cell Microenviron."},{"key":"24889_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.taap.2017.07.018","volume":"332","author":"E Caron-Beaudoin","year":"2017","unstructured":"Caron-Beaudoin, E., Viau, R., Hudon-Thibeault, A. A., Vaillancourt, C. & Sanderson, J. T. The use of a unique co-culture model of fetoplacental steroidogenesis as a screening tool for endocrine disruptors: The effects of neonicotinoids on aromatase activity and hormone production. Toxicol. Appl. Pharmacol. 332, 15\u201324 (2017).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"24889_CR15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1289\/ehp.9758","volume":"115","author":"WQ Fan","year":"2007","unstructured":"Fan, W. Q. et al. Atrazine-induced aromatase expression is SF-1 dependent: Implications for endocrine disruption in wildlife and reproductive cancers in humans. Environ. Health Perspect. 115, 720\u2013727 (2007).","journal-title":"Environ. Health Perspect."},{"key":"24889_CR16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s11356-010-0396-x","volume":"18","author":"M Hecker","year":"2011","unstructured":"Hecker, M. et al. The OECD validation program of the H295R steroidogenesis assay: Phase 3 Final inter-laboratory validation study. Environ. Sci. Pollut. Res. 18, 503\u2013515 (2011).","journal-title":"Environ. Sci. Pollut. Res."},{"key":"24889_CR17","doi-asserted-by":"crossref","unstructured":"Lucia Pinto, C., Markey, K., Dix, D. & Browne, P. Identification of candidate reference chemicals for in vitro steroidogenesis assays. Toxicol. Vitr. 47, 103\u2013119 (2018).","DOI":"10.1016\/j.tiv.2017.11.003"},{"key":"24889_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tox.2017.02.010","volume":"381","author":"P Strajhar","year":"2017","unstructured":"Strajhar, P. et al. Steroid profiling in H295R cells to identify chemicals potentially disrupting the production of adrenal steroids. Toxicology 381, 51\u201363 (2017).","journal-title":"Toxicology"},{"key":"24889_CR19","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1021\/acs.chemrestox.6b00135","volume":"29","author":"AM Richard","year":"2016","unstructured":"Richard, A. M. et al. ToxCast chemical landscape: Paving the road to 21st century toxicology. Chem. Res. Toxicol. 29, 1225\u20131251 (2016).","journal-title":"Chem. Res. Toxicol."},{"key":"24889_CR20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/toxsci\/kfw002","volume":"150","author":"AL Karmaus","year":"2016","unstructured":"Karmaus, A. L., Toole, C. M., Filer, D. L., Lewis, K. C. & Martin, M. T. High-Throughput screening of chemical effects on steroidogenesis using H295R human adrenocortical carcinoma cells. Toxicol. Sci. 150, 323\u2013332 (2016).","journal-title":"Toxicol. Sci."},{"key":"24889_CR21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/toxsci\/kfx274","volume":"162","author":"DE Haggard","year":"2018","unstructured":"Haggard, D. E. et al. High-throughput H295R steroidogenesis assay: Utility as an alternative and a statistical approach to characterize effects on steroidogenesis. Toxicol. Sci. 162, 509\u2013534 (2018).","journal-title":"Toxicol. Sci."},{"key":"24889_CR22","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2019.104510","volume":"109","author":"DE Haggard","year":"2019","unstructured":"Haggard, D. E., Setzer, R. W., Judson, R. S. & Paul Friedman, K. Development of a prioritization method for chemical-mediated effects on steroidogenesis using an integrated statistical analysis of high-throughput H295R data. Regul. Toxicol. Pharmacol. 109, 104510 (2019).","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"24889_CR23","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/cncr.22653","volume":"109","author":"RA Rudel","year":"2007","unstructured":"Rudel, R. A., Attfield, K. R., Schifano, J. N. & Brody, J. G. Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention. Cancer 109, 2635\u20132666 (2007).","journal-title":"Cancer"},{"key":"24889_CR24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13321-017-0247-6","volume":"9","author":"AJ Williams","year":"2017","unstructured":"Williams, A. J. et al. The CompTox chemistry dashboard: A community data resource for environmental chemistry. J. Cheminform. 9, 61 (2017).","journal-title":"J. Cheminform."},{"key":"24889_CR25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/ci100176x","volume":"50","author":"D Fourches","year":"2010","unstructured":"Fourches, D., Muratov, E. & Tropsha, A. Trust, but verify: On the importance of chemical structure curation in cheminformatics and QSAR modeling research. J. Chem. Inf. Model. 50, 1189\u20131204 (2010).","journal-title":"J. Chem. Inf. Model."},{"key":"24889_CR26","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1021\/acs.jcim.6b00129","volume":"56","author":"D Fourches","year":"2016","unstructured":"Fourches, D., Muratov, E. & Tropsha, A. Trust, but verify II: A practical guide to chemogenomics data curation. J. Chem. Inf. Model. 56, 1243\u20131252 (2016).","journal-title":"J. Chem. Inf. Model."},{"key":"24889_CR27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13321-018-0263-1","volume":"10","author":"K Mansouri","year":"2018","unstructured":"Mansouri, K., Grulke, C. M., Judson, R. S. & Williams, A. J. OPERA models for predicting physicochemical properties and environmental fate endpoints. J. Cheminform. 10, 10 (2018).","journal-title":"J. Cheminform."},{"key":"24889_CR28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF00337288","volume":"43","author":"T Kohonen","year":"1982","unstructured":"Kohonen, T. Self-organized formation of topologically correct feature maps. Biol. Cybern. 43, 59\u201369 (1982).","journal-title":"Biol. Cybern."},{"key":"24889_CR29","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1021\/ci500667v","volume":"55","author":"C Yang","year":"2015","unstructured":"Yang, C. et al. New publicly available chemical query language, CSRML, to support chemotype representations for application to data mining and modeling. J. Chem. Inf. Model. 55, 510\u2013528 (2015).","journal-title":"J. Chem. Inf. Model."},{"key":"24889_CR30","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/jm4004285","volume":"57","author":"A Cherkasov","year":"2014","unstructured":"Cherkasov, A. et al. QSAR modeling: Where have you been? Where are you going to?. J. Med. Chem. 57, 4977\u20135010 (2014).","journal-title":"J. Med. Chem."},{"key":"24889_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/ci400572x","volume":"54","author":"A Golbraikh","year":"2014","unstructured":"Golbraikh, A., Muratov, E., Fourches, D. & Tropsha, A. Data set modelability by QSAR. J. Chem. Inf. Model. 54, 1\u20134 (2014).","journal-title":"J. Chem. Inf. Model."},{"key":"24889_CR32","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.2174\/138161207782794257","volume":"13","author":"A Tropsha","year":"2007","unstructured":"Tropsha, A. & Golbraikh, A. Predictive QSAR modeling workflow, model applicability domains, and virtual screening. Curr. Pharm. Des. 13, 3494\u20133504 (2007).","journal-title":"Curr. Pharm. Des."},{"key":"24889_CR33","volume-title":"Classification and regression trees","author":"L Breiman","year":"1984","unstructured":"Breiman, L., Friedman, J. H., Olshen, R. A. & Stone, C. J. Classification and regression trees (Springer, 1984)."},{"key":"24889_CR34","doi-asserted-by":"publisher","unstructured":"Ripley, B. D. Pattern Recognition and Neural Networks. Advances in Pattern Recognition Research (Cambridge University Press, 1996). https:\/\/doi.org\/10.1017\/CBO9780511812651.","DOI":"10.1017\/CBO9780511812651"},{"key":"24889_CR35","first-page":"273","volume":"20","author":"C Cortes","year":"1995","unstructured":"Cortes, C. & Vapnik, V. Support-vector networks. Mach. Learn. 20, 273\u2013297 (1995).","journal-title":"Mach. Learn."},{"key":"24889_CR36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forest. Mach. Learn. 45, 5\u201332 (2001).","journal-title":"Mach. Learn."},{"key":"24889_CR37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0167-7012(00)00201-3","volume":"43","author":"IA Basheer","year":"2000","unstructured":"Basheer, I. A. & Hajmeer, M. Artificial neural networks: Fundamentals, computing, design, and application. J. Microbiol. Methods 43, 3\u201331 (2000).","journal-title":"J. Microbiol. Methods"},{"key":"24889_CR38","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1038\/s41598-020-60747-3","volume":"10","author":"A Borrel","year":"2020","unstructured":"Borrel, A. et al. High-throughput screening to predict chemical-assay interference. Sci. Rep. 10, 3986 (2020).","journal-title":"Sci. Rep."},{"key":"24889_CR39","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1021\/acs.jcim.1c00160","volume":"61","author":"C Esposito","year":"2021","unstructured":"Esposito, C., Landrum, G. A., Schneider, N., Stiefl, N. & Riniker, S. GHOST: Adjusting the decision threshold to handle imbalanced data in machine learning. J. Chem. Inf. Model. 61, 2623\u20132640 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"24889_CR40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jsbmb.2008.06.005","volume":"111","author":"V Kumar","year":"2008","unstructured":"Kumar, V., Majumdar, C. & Roy, P. Effects of endocrine disrupting chemicals from leather industry effluents on male reproductive system. J. Steroid Biochem. Mol. Biol. 111, 208\u2013216 (2008).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"24889_CR41","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s11356-009-0285-3","volume":"17","author":"EB Higley","year":"2010","unstructured":"Higley, E. B., Newsted, J. L., Zhang, X., Giesy, J. P. & Hecker, M. Assessment of chemical effects on aromatase activity using the H295R cell line. Environ. Sci. Pollut. Res. 17, 1137\u20131148 (2010).","journal-title":"Environ. Sci. Pollut. Res."},{"key":"24889_CR42","first-page":"3843","volume":"81","author":"VR Agarwal","year":"1996","unstructured":"Agarwal, V. R., Bulun, S. E., Leitch, M., Rohrich, R. & Simpson, E. R. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J. Clin. Endocrinol. Metab. 81, 3843\u20133849 (1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"24889_CR43","doi-asserted-by":"crossref","first-page":"04701","DOI":"10.1289\/EHP2698","volume":"126","author":"\u00c9 Caron-Beaudoin","year":"2018","unstructured":"Caron-Beaudoin, \u00c9., Viau, R. & Sanderson, J. T. Effects of neonicotinoid pesticides on promoter-specific aromatase (CYP19) expression in Hs578t breast cancer cells and the role of the VEGF pathway. Environ. Health Perspect. 126, 04701 (2018).","journal-title":"Environ. Health Perspect."},{"key":"24889_CR44","first-page":"332","volume":"1","author":"SM Abd Elrahman","year":"2013","unstructured":"Abd Elrahman, S. M. & Abraham, A. A review of class imbalance problem. J. Netw. Innov. Comput. 1, 332\u2013340 (2013).","journal-title":"J. Netw. Innov. Comput."},{"key":"24889_CR45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3233\/IDA-2002-6504","volume":"6","author":"N Japkowicz","year":"2002","unstructured":"Japkowicz, N. & Stephen, S. The class imbalance problem: A systematic study. Intell. Data Anal. 6, 429\u2013449 (2002).","journal-title":"Intell. Data Anal."},{"key":"24889_CR46","doi-asserted-by":"publisher","first-page":"108937","DOI":"10.1016\/j.steroids.2021.108937","volume":"177","author":"Oukseub Lee","year":"2022","unstructured":"Lee, Q. et al. Association of genetic polymorphisms with local steroid metabolism in human benign breasts. Steroids 177, 108937. https:\/\/doi.org\/10.1016\/j.steroids.2021.108937 (2022).","journal-title":"Steroids"},{"issue":"2","key":"24889_CR47","doi-asserted-by":"publisher","first-page":"e467","DOI":"10.1210\/clinem\/dgab713","volume":"107","author":"Susanna C Larsson","year":"2021","unstructured":"Larsson, S. C. et al. Serum estradiol and 20 site-specific cancers in women: Mendelian randomization study. J. Clin. Endocrinol. Metab. 107(2), e467\u2013e474. https:\/\/doi.org\/10.1210\/clinem\/dgab713 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"24889_CR48","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1210\/endrev\/bnz001","volume":"41","author":"Britton Trabert","year":"2019","unstructured":"Trabert, B., Sherman, M. E., Kannan, N. & Stanczyk F. Z. Progesterone and breast cancer. Endocr. Rev. 41(2), 320\u2013344 https:\/\/doi.org\/10.1210\/endrev\/bnz001 (2019).","journal-title":"Endocr. Rev."},{"key":"24889_CR49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bpobgyn.2019.11.006","volume":"65","author":"MA Thorat","year":"2020","unstructured":"Thorat, M. A. & Balasubramanian, R. Breast cancer prevention in high-risk women. Best Pract. Res. Clin. Obstet. Gynaecol. 65, 18\u201331 (2020).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"24889_CR50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(19)32955-1","volume":"395","author":"J Cuzick","year":"2020","unstructured":"Cuzick, J. et al. Use of anastrozole for breast cancer prevention (IBIS-II): Long-term results of a randomised controlled trial. Lancet 395, 117\u2013122 (2020).","journal-title":"Lancet"},{"key":"24889_CR51","doi-asserted-by":"crossref","first-page":"T81","DOI":"10.1530\/JME-20-0091","volume":"65","author":"C Brisken","year":"2020","unstructured":"Brisken, C. & Scabia, V. Progesterone receptor signaling in the normal breast and its implications for cancer. J. Mol. Endocrinol. 65, T81\u2013T94 (2020).","journal-title":"J. Mol. Endocrinol."},{"key":"24889_CR52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3892\/ol.2020.11945","volume":"20","author":"GM Calaf","year":"2020","unstructured":"Calaf, G. M., Ponce-Cusi, R., Aguayo, F., Mu\u00f1oz, J. P. & Bleak, T. C. Endocrine disruptors from the environment affecting breast cancer (review). Oncol. Lett. 20, 19\u201332 (2020).","journal-title":"Oncol. Lett."},{"key":"24889_CR53","unstructured":"EPA. EPA\u2019s Endocrine Disruptor Screening Program (EDSP). https:\/\/www.epa.gov\/endocrine-disruption\/endocrine-disruptor-screening-program-edsp-overview#approach."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24889-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24889-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24889-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T10:08:50Z","timestamp":1670234930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24889-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["24889"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-24889-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,30]]},"assertion":[{"value":"10 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20647"}}